Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation

FEBS Letters

Volumn 582, Issue 2, 2008, Pages 365-371

  Bokui, Nobuyuki ^a   Otani, Takayuki ^b   Igarashi, Koichi ^b   Kaku, Junichiro ^c   Oda, Mitsuo ^d   Nagaoka, Tadahiro ^e   Seno, Masaharu ^e   Tatematsu, Kenji ^a   Okajima, Toshihide ^a   Matsuzaki, Takashi ^a   Ting, Kang ^f   Tanizawa, Katsuyuki ^a   Kuroda, Shun'ichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b RandD Division   (Japan)

^c Hirai Dental Clinic   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Bone; Differentiation; MAP kinase; Osteoblast; Tyrosine phosphorylation

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NOVEL EPIDERMAL GROWTH FACTOR LIKE PROTEIN 1; RAS PROTEIN; SMAD PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; ENZYME ACTIVATION; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; OSTEOBLASTS; PHOSPHORYLATION; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 38049046208     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.12.006     Document Type: Article

References (26)

1. Hughes F.J., Turner W., Belibasakis G., and Martuscelli G. Effects of growth factors and cytokines on osteoblast differentiation. Periodontology 41 (2000) 48-72
2. Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrinology 24 (2003) 218-235
3. Chen D., Zhao M., and Mundy G.R. Bone morphogenetic proteins. Growth Factors 22 (2004) 233-241
4. Ting K., Vastardis H., Mulliken J.B., Soo C., Tieu A., Do H., Kwong E., Bertolami C.N., Kawamoto H., Kuroda S., and Longaker M.T. Human NELL-1 expressed in unilateral coronal synostosis. J. Bone Miner. Res. 14 (1999) 80-89
5. Kuroda S., Oyasu M., Kawakami M., Kanayama N., Tanizawa K., Saito N., Abe T., Matsuhashi S., and Ting K. Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. Biochem. Biophys. Res. Commun. 265 (1999) 79-86
6. Zhang X., Kuroda S., Carpenter D., Nishimura I., Soo C., Moats R., Iida K., Wisner E., Hu F.Y., Miao S., Beanes S., Dang C., Vastardis H., Longaker M., Tanizawa K., Kanayama N., Saito N., and Ting K. Craniosynostosis in transgenic mice overexpressing Nell-1. J. Clin. Invest. 18 (2002) 2126-2134
7. Desai J., Shannon M.E., Johnson M.D., Ruff D.W., Hughes L.A., Kerley M.K., Carpenter D.A., Johnson D.K., Rinchik E.M., and Culiat C.T. Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects. Hum. Mol. Genet. 15 (2006) 1329-1341
8. Aghaloo T., Cowan C.M., Chou Y.F., Zhang X., Lee H., Miao S., Hong N., Kuroda S., Wu B., Ting K., and Soo C. Nell-1-induced bone regeneration in calvarial defects. Am. J. Pathol. 169 (2006) 903-915
9. Cowan C.M., Jiang X., Hsu T., Soo C., Zhang B., Wang J.Z., Kuroda S., Wu B., Zhang Z., Zhang X., and Ting K. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts. J. Bone Miner. Res. 22 (2007) 918-930
10. Xiao G., Gopalakrishnan R., Jiang D., Reith E., Benson M.D., and Franceschi R.T. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J. Bone Miner. Res. 17 (2002) 101-110
11. Aihara K., Kuroda S., Kanayama N., Matsuyama S., Tanizawa K., and Horie M. A neuron-specific EGF family protein, NELL2, promotes survival of neurons through mitogen-activated protein kinases. Brain Res. Mol. Brain Res. 116 (2004) 86-93
12. Schindeler A., and Little D.G. Ras-MAPK signaling in osteogenic differentiation: friend or foe?. J. Bone Miner. Res. 21 (2006) 1331-1338
13. Miyazono K., Maeda S., and Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16 (2005) 251-263
14. Katagiri T., Imada M., Yanai T., Suda T., Takahashim N., and Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cell. 7 (2002) 949-960
15. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
16. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., and Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 30 (1997) 765-771
17. Xiao G., Jiang D., Gopalakrishnan R., and Franceschi R.T. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J. Biol. Chem. 277 (2002) 36181-36187
18. Qiao M., Shapiro P., Kumar R., and Passaniti A. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. J. Biol. Chem. 279 (2004) 42709-42718
19. Xiao G., Jiang D., Thomas P., Benson M.D., Guan K., Karsenty G., and Franceschi R.T. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J. Biol. Chem. 275 (2000) 4453-4459
20. Klees R.F., Salasznyk R.M., Kingsley K., Williams W.A., Boskey A., and Plopper G.E. Laminin-5 induces osteogenic gene expression in human mesenchymal stem cells through an ERK-dependent pathway. Mol. Biol. Cell 16 (2005) 881-890
21. Natsume T., Tomita S., Iemura S., Kinto N., Yamaguchi A., and Ueno N. Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4. J. Biol. Chem. 272 (1997) 11535-11540
22. Calzada M.J., Sipes J.M., Krutzsch H.C., Yurchenco P.D., Annis D.S., Mosher D.F., and Roberts D.D. Recognition of the N-terminal modules of thrombospondin-1 and thrombospondin-2 by alpha6beta1 integrin. J. Biol. Chem. 278 (2004) 40679-40687
23. Salasznyk R.M., Klees R.F., Boskey A., and Plopper G.E. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5. J. Cell Biochem. 100 (2007) 499-514
24. Kanno T., Takahashi T., Tsujisawa T., Ariyoshi W., and Nishihara T. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. J. Cell Biochem. 101 (2007) 1266-1277
25. Hohenester E., Tisi D., Talts J.F., and Timpl R. The crystal structure of a laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin. Mol. Cell 4 (1999) 783-792
26. Givant-Horwitz V., Davidson B., and Reich R. Laminin-induced signaling in tumor cells. Cancer Lett. 223 (2005) 1-10